Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.

= icon !

‘

(TO BE PUBLISHED IN THE GAZETTE OF INDIA EXTRAORDINARY (PART-I (SECTION-1) Government of India Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade

Public Notice No.46 /2024-25 New Delhi, Dated 6h February, 2025

Subject: Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.

In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet. Export Product | __ Quantity [SLNo.[Import Items | Quantity Erythromycin Stearate 1 Number 1 |Erythromycin 334 mg. tablets-250 mg. Tablet Stearate (each tablet contains erythromycin stearate equivalent to 250 mg. of Erythromycin

Note: For other variants of export items, norms may be worked out on a pro-rata basis.

Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with immediate effect.

roa Vs (Santosh Kumar Sarangi) Director General of Foreign Trade Ex-officio Addl. Secretary to the Government of India e-mail: dgft@nic.in

(Issued from File No. 01/82/0017/AM-25/DES-II1)